[
  {
    "ts": "2025-10-06T21:18:05+00:00",
    "headline": "Gilead Scores A 'Solid Win' For Its Biggest Moneymaker; Shares Jump",
    "summary": "Gilead stock popped Monday after the biotech giant said it signed deals with three generic drugmakers to delay their Biktarvy copycats.",
    "url": "https://www.investors.com/news/technology/gilead-stock-biktarvy-patent-deal/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "71435eda-c89b-34d3-8f64-a4d65e885c54",
      "content": {
        "id": "71435eda-c89b-34d3-8f64-a4d65e885c54",
        "contentType": "STORY",
        "title": "Gilead Scores A 'Solid Win' For Its Biggest Moneymaker; Shares Jump",
        "description": "",
        "summary": "Gilead stock popped Monday after the biotech giant said it signed deals with three generic drugmakers to delay their Biktarvy copycats.",
        "pubDate": "2025-10-06T21:18:05Z",
        "displayTime": "2025-10-06T21:18:05Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/71435eda-c89b-34d3-8f64-a4d65e885c54/gilead-scores-a-solid-win-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/shVGxj7bu_u.CpYzNTXRdw--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WU5OlgKO09tNMial_TfFPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c41f2b75ef43110c88cfcb472262eb79.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/gilead-stock-biktarvy-patent-deal/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LUPIN.BO"
            },
            {
              "symbol": "LAURUSLABS.NS"
            },
            {
              "symbol": "CIPLA.NS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-06T19:52:16+00:00",
    "headline": "Sector Update: Health Care Stocks Retreat Late Afternoon",
    "summary": "Health care stocks declined late Monday afternoon, with the NYSE Health Care Index easing 0.3% and t",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-retreat-195216588.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0adbe2c2-594a-3917-8445-1381a36473d1",
      "content": {
        "id": "0adbe2c2-594a-3917-8445-1381a36473d1",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Retreat Late Afternoon",
        "description": "",
        "summary": "Health care stocks declined late Monday afternoon, with the NYSE Health Care Index easing 0.3% and t",
        "pubDate": "2025-10-06T19:52:16Z",
        "displayTime": "2025-10-06T19:52:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-retreat-195216588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-retreat-195216588.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            },
            {
              "symbol": "NBIX"
            },
            {
              "symbol": "XLV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-06T13:19:55+00:00",
    "headline": "Gilead stock rises after settling Biktarvy patent disputes",
    "summary": "Investing.com -- Gilead Sciences Inc. (NASDAQ:GILD) stock rose 4.5% Monday after the company announced it had settled patent disputes with multiple generic drugmakers over its HIV treatment Biktarvy.",
    "url": "https://finance.yahoo.com/news/gilead-stock-rises-settling-biktarvy-131955964.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "c8708d45-4b1d-3b2a-8823-d5fbcf4cf02c",
      "content": {
        "id": "c8708d45-4b1d-3b2a-8823-d5fbcf4cf02c",
        "contentType": "STORY",
        "title": "Gilead stock rises after settling Biktarvy patent disputes",
        "description": "",
        "summary": "Investing.com -- Gilead Sciences Inc. (NASDAQ:GILD) stock rose 4.5% Monday after the company announced it had settled patent disputes with multiple generic drugmakers over its HIV treatment Biktarvy.",
        "pubDate": "2025-10-06T13:19:55Z",
        "displayTime": "2025-10-06T13:19:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-stock-rises-settling-biktarvy-131955964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-stock-rises-settling-biktarvy-131955964.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "LUPIN.BO"
            },
            {
              "symbol": "CIPLA.NS"
            },
            {
              "symbol": "LAURUSLABS.NS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-06T10:07:00+00:00",
    "headline": "Gilead delays arrival of Biktarvy copycats; CDC updates vaccine schedule",
    "summary": "A settlement could extend the exclusivity of the world’s best-selling HIV medicine to 2036. Elsewhere, an AstraZeneca drug acquisition paid more dividends and a Vertex veteran became Stoke’s full-time CEO.",
    "url": "https://www.biopharmadive.com/news/gilead-delays-arrival-of-biktarvy-copycats-cdc-updates-vaccine-schedule/802011/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "5d194364-2b8d-38e8-b6e5-c18e51239e80",
      "content": {
        "id": "5d194364-2b8d-38e8-b6e5-c18e51239e80",
        "contentType": "STORY",
        "title": "Gilead delays arrival of Biktarvy copycats; CDC updates vaccine schedule",
        "description": "",
        "summary": "A settlement could extend the exclusivity of the world’s best-selling HIV medicine to 2036. Elsewhere, an AstraZeneca drug acquisition paid more dividends and a Vertex veteran became Stoke’s full-time CEO.",
        "pubDate": "2025-10-06T10:07:00Z",
        "displayTime": "2025-10-06T10:07:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/gilead-delays-arrival-of-biktarvy-copycats-cdc-updates-vaccine-schedule/802011/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-delays-arrival-biktarvy-copycats-100700559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "STOK"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]